Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23926890 | 0.94 | — | — | |
| SCHEMBL136714 | 0.94 | — | — | |
| Adamantane SCHEMBL2394879 | 0.89 | CYP2C9 (0.38) | CYP2C9 | |
| SCHEMBL1230616 | 0.82 | SLC22A2 (0.31) | CYP2C9 | |
| SCHEMBL8189 | 0.82 | — | — | |
| SCHEMBL3226595 | 0.82 | SLC22A2 (0.31) | CYP2C9 | |
| Adamantane SCHEMBL9016497 | 0.82 | CYP2C9 (0.46) | CYP2C9 | |
| Adamantane SCHEMBL29707714 | 0.82 | CYP2C9 (0.46) | CYP2C9 | |
| Adamantane SCHEMBL12761 | 0.82 | CYP2C9 (0.46) | CYP2C9 | |
| Adamantane SCHEMBL1527414 | 0.82 | CYP2C9 (0.46) | CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4053223-B1 | COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS | F2MB ENG UG HAFTUNGSBESCHRAENKT (DE) | 2025-05-14 | — | — | EP | claimed |
| US-20240174871-A1 | Compositions for Use in Optical Measurement Technology Applications | F2MB-ENGINEERING UG (DE) | 2024-05-30 | — | — | US | claimed |
| CN-117440992-A | Use of a composition in optical measurement applications | F2MB-工程公司 | 2024-01-23 | — | — | CN | claimed |
| WO-2022184834-A1 | COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS | F2MB-ENGINEERING UG (DE) | 2022-09-09 | — | — | WO | claimed |
| EP-4053223-A1 | COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS | F2MB-Engineering UG (haftungsbeschränkt) (DE) | 2022-09-07 | — | — | EP | claimed |
| EP-4728019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Sable Rubber IP Pty Limited (AU) | 2026-04-22 | — | — | EP | disclosed |
| US-20250185505-A1 | NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2025-06-05 | — | — | US | disclosed |
| US-20250171684-A1 | AROMATIC HETREOCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2025-05-29 | — | — | US | disclosed |
| EP-4053223-B1 | COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS | F2MB ENG UG HAFTUNGSBESCHRAENKT (DE) | 2025-05-14 | — | — | EP | disclosed |
| CN-119498028-A | Carbon mold for DRAM capacitor | 应用材料公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-119241343-A | Highly adamantane type phloroglucinol compound and preparation method and application thereof | 中日友好医院(中日友好临床医学研究所) | 2025-01-03 | — | — | CN | disclosed |
| WO-2024257019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Molectra Rubber IP Pty Ltd (AU) | 2024-12-19 | — | — | WO | disclosed |
| US-20020028808-A1 | Use of potassium channel agonists for the treatment of cancer | NOVO NORDISK A/S (DK) | 2002-03-07 | — | — | US | disclosed |
| WO-2002000222-A1 | USE OF POTASSIUM CHANNEL AGONISTS FOR THE TREATMENT OF CANCER | NOVO NORDISK A/S (DK) | 2002-01-03 | — | — | WO | disclosed |
| WO-2002000223-A1 | USE OF POTASSIUM CHANNEL AGONISTS FOR REDUCING FAT FOOD COMSUMPTION | NOVO NORDISK A/S (DK) | 2002-01-03 | — | — | WO | disclosed |
| US-6329367-B1 | NERVOUS SYSTEM DISORDERS AND CARDIOVASCULAR DISORDERS | NOVO NORDISK A/S (DK) | 2001-12-11 | — | — | US | disclosed |
| EP-1140945-A1 | FUSED 1,2,4-THIADIAZINE DERIVATIVES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000076505-A1 | AMIDE SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000037474-A1 | FUSED 1,2,4-THIADIAZINE DERIVATIVES, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2000-06-29 | — | — | WO | disclosed |
| WO-1995028155-A1 | PHOSPHONATE DERIVATIVES OF LIPOPHILIC AMINES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171684-A1 | AROMATIC HETREOCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES | AHR, PAH, DDT | CYP2C9 39/4885 |
| US-20250185505-A1 | NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES | NES, NUDC, HCN2 | CYP2C9 857/4885 |
| US-20020028808-A1 | Use of potassium channel agonists for the treatment of cancer | KCNN3, KCNN1, KCNN2 | CYP2C9 3315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.